Table 2 Details and sources of primary data collection
From: Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
Parameters | Components | Sources of data | Number of patients |
|---|---|---|---|
Direct medical cost | Number of hospital admissions/outpatient visits | Patient interviews | 48 (FC I = 18, FC II = 19, FC III = 10, FC IV = 1) |
Hospital admission and outpatient visit costs e.g. other drug cost, laboratory services, etc. | Hospital billing | ||
Cost of pulmonary selective drugs | Cost of sildenafil and beraprost | Hospital billing | |
Direct non-medical cost | Travel, consumption, accommodation expenses, opportunity cost of caregivers, cost of daily supportive devices | Patient interviews | |
Utility | – | Patient interviews |